Jul 24, 2018 - Biogen (BIIB) beats estimates on both counts in the second quarter. The company's multiple sclerosis drugs' sales up sequentially amid competition.
Jan 15, 2019 - FDA grants priority review to Pfizer's (PFE) regulatory filing looking for approval of pipeline candidate, tafamidis to treat transthyretin amyloid cardiomyopathy.
Jan 24, 2019 - Ironwood (IRWD) begins a phase I study on CNS-penetrant soluble guanylate cyclase stimulator, IW-6463, for treating severe CNS disorders.
Jan 28, 2019 - Is (IONS) Outperforming Other Medical Stocks This Year?
Feb 20, 2019 - Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Feb 20, 2019 - The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
Apr 18, 2019 - Here are 4 large-cap stocks from varied industries that may be worth your money.
May 01, 2019 - Ion Geophysical (IO) delivered earnings and revenue surprises of -97.40% and 8.06%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
May 02, 2019 - Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.